zanamivir has been researched along with methylprednisolone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Down, J; Grant, PR; Howell, DC; Kidd, IM; Nastouli, E; Shulman, R; Singer, M | 1 |
| Hirayama, T; Ikeda, K; Ito, H; Iwasaki, Y; Kano, O; Kawabe, K; Nakamura, Y; Yoshii, Y | 1 |
4 other study(ies) available for zanamivir and methylprednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
H1N1 pneumonitis treated with intravenous zanamivir.
Topics: Administration, Inhalation; Adult; Anti-Inflammatory Agents; Antiviral Agents; Bronchoalveolar Lavage Fluid; Critical Care; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Infusions, Intravenous; Methylprednisolone; Neutropenia; Pneumonia, Viral; Treatment Outcome; Viral Load; Zanamivir | 2009 |
Influenza-associated monophasic neuromyelitis optica.
Topics: Adolescent; Anti-Inflammatory Agents; Antiviral Agents; Aquaporin 4; Autoantibodies; Female; Humans; Influenza A virus; Influenza, Human; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Prednisolone; Zanamivir | 2011 |